RankAlpha logo
Back to Rankings

SORA

AsiaStrategyF
Nasdaq / Consumer Discretionary Distribution & Retail
Last Price
Quote time unavailable
View Chart
Documents
1
Stored
Transcripts
0
Recent loaded
Latest report
2026-05-07
Investor release

Document history

Earnings documents stored for SORA.

1 shown
Investor releaseQuarter not tagged2026-05-07

AsiaStrategy's (NASDAQ:SORA) Earnings Might Be Weaker Than You Think

Simply Wall St.
Shareholders didn't seem to be thrilled with AsiaStrategy's (NASDAQ:SORA) recent earnings report, despite healthy profit numbers. Our analysis suggests they may be concerned about some underlying details. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. As finance nerds would already know, the accrual ratio from cashflow is a key measure for assessing how well a company's free cash flow (FCF) matches its profit. In plain english, this ratio subtracts FCF from net profit, and divides that number by the company's average operating assets over that period. You could think of the accrual ratio from cashflow as the 'non-FCF profit ratio'. That means a negative accrual ratio is a good thing, because it shows that the company is bringing in more free cash flow than its profit would suggest. While it's not a problem to have a positive accrual ratio, indicating a certain level of non-cash profits, a high accrual ratio is arguably a bad thing, because it indicates paper profits are not matched by cash flow. Notably, there is some academic evidence that suggests that a high accrual ratio is a bad sign for near-term profits, generally speaking. AsiaStrategy has an accrual ratio of 1.61 for the year to December 2025. Statistically speaking, that's a real negative for future earnings. And indeed, during the period the company didn't produce any free cash flow whatsoever. Over the last year it actually had negative free cash flow of US$4.3m, in contrast to the aforementioned profit of US$12.3m. Coming off the back of negative free cash flow last year, we imagine some shareholders might wonder if its cash burn of US$4.3m, this year, indicates high risk. However, that's not all there is to consider. We can see that unusual items have impacted its statutory profit, and therefore the accrual ratio. Check out our latest analysis for AsiaStrategy Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of AsiaStrategy. Given the accrual ratio, it's not overly surprising that AsiaStrategy's profit was boosted by unusual items worth US$15m in the last twelve months. While we like to see profit increases, we tend to be a little more cautious when unusual items have made a big contribution. When we crunched the numbers on thousands of publicly listed companie…Read full document

Shareholders didn't seem to be thrilled with AsiaStrategy's (NASDAQ:SORA) recent earnings report, despite healthy profit numbers. Our analysis suggests they may be concerned about some underlying details. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. As finance nerds would already know, the accrual ratio from cashflow is a key measure for assessing how well a company's free cash flow (FCF) matches its profit. In plain english, this ratio subtracts FCF from net profit, and divides that number by the company's average operating assets over that period. You could think of the accrual ratio from cashflow as the 'non-FCF profit ratio'. That means a negative accrual ratio is a good thing, because it shows that the company is bringing in more free cash flow than its profit would suggest. While it's not a problem to have a positive accrual ratio, indicating a certain level of non-cash profits, a high accrual ratio is arguably a bad thing, because it indicates paper profits are not matched by cash flow. Notably, there is some academic evidence that suggests that a high accrual ratio is a bad sign for near-term profits, generally speaking. AsiaStrategy has an accrual ratio of 1.61 for the year to December 2025. Statistically speaking, that's a real negative for future earnings. And indeed, during the period the company didn't produce any free cash flow whatsoever. Over the last year it actually had negative free cash flow of US$4.3m, in contrast to the aforementioned profit of US$12.3m. Coming off the back of negative free cash flow last year, we imagine some shareholders might wonder if its cash burn of US$4.3m, this year, indicates high risk. However, that's not all there is to consider. We can see that unusual items have impacted its statutory profit, and therefore the accrual ratio. Check out our latest analysis for AsiaStrategy Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of AsiaStrategy. Given the accrual ratio, it's not overly surprising that AsiaStrategy's profit was boosted by unusual items worth US$15m in the last twelve months. While we like to see profit increases, we tend to be a little more cautious when unusual items have made a big contribution. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. And, after all, that's exactly what the accounting terminology implies. AsiaStrategy had a rather significant contribution from unusual items relative to its profit to December 2025. All else being equal, this would likely have the effect of making the statutory profit a poor guide to underlying earnings power. Summing up, AsiaStrategy received a nice boost to profit from unusual items, but could not match its paper profit with free cash flow. For all the reasons mentioned above, we think that, at a glance, AsiaStrategy's statutory profits could be considered to be low quality, because they are likely to give investors an overly positive impression of the company. If you want to do dive deeper into AsiaStrategy, you'd also look into what risks it is currently facing. To help with this, we've discovered 3 warning signs (2 are a bit unpleasant!) that you ought to be aware of before buying any shares in AsiaStrategy. Our examination of AsiaStrategy has focussed on certain factors that can make its earnings look better than they are. And, on that basis, we are somewhat skeptical. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

As of 2026-05-18 • Updated weeklySource: Earnings sourceIngestion runbook